TipHub

₹49

▼ -1.99 -3.90%

As of 29 Jul 2026 · delayed

BSE Listed

Oxygenta Pharmaceutical Limited (524636)

Volume: 20,903Avg Vol 1W: 13,229Avg Vol 1M: 7,78052W Range:₹43₹109
BSE www.oxygentapharma.com AI Report
Key Ratios
Checked just now
Market Cap₹181 Cr
Current Price₹49
Previous Close₹50.99
High / Low (52w)₹109 / ₹43
Volume20,903
Avg Vol (1W)13,229
Avg Vol (1M)7,780
Stock P/E—
Book Value₹-11.54
Dividend Yield0%
ROE41.16%
ROA-11.34%
Revenue (TTM)—
Revenue Growth—
Profit Margin-10.06%
Total Debt—
Shares Outstanding4 Cr
Face Value—
EPS (TTM)₹0
P/B—
Debt / Equity0
50 DMA₹49.47
200 DMA₹54.74
Day change-3.90%
Price Chart
₹49▼ 52.33% · 1Y
₹112₹453.6L
2025-07-29
2026-07-29

20-day avg volume: 8K shares

Pros
  • Healthy return on equity of 41.2%.
  • Company is almost debt-free.
  • Revenue grew 179% YoY.
Cons
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹14 Cr₹33 Cr₹49 Cr₹15 Cr₹14 Cr₹34 Cr₹50 Cr₹37 Cr
EBITDA₹-2 Cr₹-5 Cr₹-1 Cr₹-8 Cr₹-5 Cr₹-5 Cr₹1 Cr₹0 Cr
Net Profit₹-3 Cr₹-4 Cr₹-2 Cr₹-6 Cr₹-5 Cr₹-5 Cr₹-2 Cr₹-2 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹14 Cr₹21 Cr₹14 Cr₹52 Cr₹61 Cr₹31 Cr₹40 Cr₹111 Cr
EBITDA₹-4 Cr₹-3 Cr₹-9 Cr₹3 Cr₹0 Cr₹-9 Cr₹-12 Cr₹-9 Cr
Net Profit₹-5 Cr₹-3 Cr₹-6 Cr₹3 Cr₹-1 Cr₹-12 Cr₹-3 Cr₹-10 Cr
EPS-4.44-3.19-5.672.87-0.48-8.15-1.04-2.69
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹17 Cr₹21 Cr₹19 Cr₹34 Cr₹31 Cr₹54 Cr₹63 Cr₹83 Cr
Total Liabilities₹49 Cr₹56 Cr₹60 Cr₹72 Cr₹66 Cr₹100 Cr₹83 Cr₹108 Cr
Equity₹-32 Cr₹-35 Cr₹-41 Cr₹-38 Cr₹-35 Cr₹-46 Cr₹-20 Cr₹-25 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-1 Cr₹-2 Cr₹-2 Cr₹-13 Cr₹3 Cr
Investing₹-7 Cr₹-5 Cr₹-10 Cr₹-4 Cr₹-11 Cr
Financing₹9 Cr₹6 Cr₹11 Cr₹17 Cr₹9 Cr
Free Cash Flow₹-1 Cr₹-2 Cr₹-2 Cr₹-13 Cr₹3 Cr
Shareholding
Promoter 56.54% Institutions 0.03% Public 43.44%
Efficiency & Working Capital
ROCE-26%
Interest Coverage-4.7
Dividend Payout—
Debtor Days17 d
Inventory Days69 d
Payable Days99 d
Cash Conversion Cycle-14 d
Working Capital Days86 d
Shareholding Details

As of 2026-06-30

Promoter56.5%
FII0%
DII0%
Institutions0%
Public43.4%
Promoter Pledge0%
No. of Shareholders10,196
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters29.7%29.7%29.7%33.7%53.3%51.1%51.1%58%58%55.9%56.5%56.5%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public70.2%70.2%70.2%66.3%46.7%48.9%48.9%42%42%44%43.4%43.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders8,9729,05110,1029,97010,15410,10710,03010,09410,17910,21510,20510,196
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Virupaksha Organics LimitedShareholding of Promoter and Promoter Group56.5%2.09 Cr
Sravani Reddy GantlaPublic Shareholding6.8%25,07,660
Subba Reddy BhimavarapuPublic Shareholding4.1%15,32,800
Sunil V. ChawdaPublic Shareholding3%10,97,629
Kumuda KatasaniPublic Shareholding2.3%8,38,291
Aakanksha M ChawdaPublic Shareholding1.5%5,69,616
Manoj S. ChawdaPublic Shareholding1.5%5,69,700
Snigdha VankineniPublic Shareholding1.5%5,43,000
Devarapally Venkateswara ReddyPublic Shareholding1.3%4,85,528
Satyanarayana Reddy BandiPublic Shareholding1.3%4,78,159
B Subba ReddyPublic Shareholding1.3%4,67,400
Chandra Mouliswar Reddy GangavaramShareholding of Promoter and Promoter Group0%12,895
Board of Directors
NameDesignationYear
Chandra Mouliswar Reddy GangavaramWTD & Executive Director2025
Balasubba Reddy MamillaWTD & Executive Director2025
Vedavathi GangavaramNon Executive Director2025
Veera Reddy AravaIndependent Non Exe. Director2025
Sidda Reddy KanuparthiIndependent Non Exe. Director2025
Sharvari Swapnil ShindeIndependent Non Exe. Director2025
Ms. Kumkum BajajCompany Sec. & Compli. Officer2025
Segments — Geography
RegionRevenueShare
Domestic Sales₹109 Cr99.9%
Export Sales₹0 Cr0.1%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10383737
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-27Board Meetings—
forthcoming2026-07-25Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500038240
202500030131
2025000819
Insider / Designated-Person Trades

2 recent disclosure(s)

Virupaksha Organics LimitedAcquisition · 2,23,632
Virupaksha Organics LimitedAcquisition · 1,95,885
Substantial Acquisitions (SAST)

3 disclosure(s)

Market13/02/2026 · 2,33,632
Market13/02/2026 · 2,23,632
Market15/12/2025 · 1,95,885
Company Information
Incorporated1990
AuditorA M Reddy & D R Reddy
Investor Email[email protected]; [email protected]; info@sso
🌐 www.oxygentapharma.com ↗

📍 Survey No 252/1 Aroor Village, Sadasivapet Mandal, Medak, Telangana, 502291

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

IEL LimitediStreet Network LimitedGagan Gases Ltd.Parker Agrochem Exports LimitedShukra Pharmaceuticals LimitedAlufluoride Ltd.Archit Organosys Ltd.Sikozy Realtors LimitedIndo AminesNatural CapsulesWelcure Drugs & Pharmaceuticals Ltd.Bharat Immunological & Biological Corporation Ltd.All “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search